top of page

Misophonia in Perimenopause: When Sound Sensitivity Spikes with Hormone Shifts

Aug 21
10 min read

Last reviewed: 08/21/2026

Reviewed by: Dr. Kiesa Kelly


Misophonia in perimenopause: why hormone shifts amplify existing sound sensitivity rather than causing the condition

You have always hated the sound of chewing. For twenty years that was a quirk — irritating, manageable, the thing your family teased you about. Then somewhere around forty-three it stopped being manageable. Now you eat in a different room. You have started resenting your partner for breathing. And the part that unsettles you most is not the sound itself; it is that nothing about the sound changed, so the change must be in you.


This article is about that specific experience: a long-standing sound sensitivity that becomes unbearable during the menopause transition. It is deliberately narrow. If you are dealing with broader sensory overload in perimenopause — heat, clothing, light, touch — that is a different and wider question, and we have covered it in perimenopause sensory overload. This piece stays with sound.


In this article, you'll learn:

  • Why misophonia is a distinct condition rather than a menopause symptom

  • What is actually known about estrogen's role in how the brain processes sound

  • The difference between amplification and onset — and why it changes what you do next

  • What the evidence does and does not support, including claims about hormone therapy


The short answer — what is actually happening

Perimenopause does not appear to cause misophonia. What it plausibly does is lower your tolerance for triggers you already had.


That distinction sounds academic until you notice how much it changes. If perimenopause caused the condition, you would be waiting for hormones to settle and hoping it resolves. If perimenopause reduced your margin around a condition you have carried for decades, then two separate things are treatable — the sound response itself, and the capacity that has been eroded around it.


Three things are worth correcting before going further, because each one sends people down an unhelpful path.


"This is a new hormonal condition." It is far more often an old condition under new conditions. The trigger sounds people describe in midlife are usually the same ones they can trace back to adolescence.


"It will resolve when my hormones settle." Possibly, in part — but a sound response that has been present for twenty years is unlikely to disappear on its own, and waiting is time not spent on something that has evidence behind it.


"I have become an unreasonable person." This is the one I hear most, and it is the least accurate. A reduced tolerance threshold is a physiological state, not a change in character — and the shame attached to it tends to keep people from mentioning it to anyone who could help.


Misophonia is a distinct condition, not a perimenopause symptom

In 2022, an expert panel used a structured consensus process to produce the first agreed definition of misophonia: a disorder of decreased tolerance to specific sounds or their associated stimuli, in which those triggers provoke intense emotional and physiological reactions out of proportion to the sound [1]. That definition emerged from a field that had used inconsistent language for years, and it is still being debated [2].


Two things follow. First, misophonia has its own identity — it is not a variant of anxiety, not a hearing problem, and not a general sensitivity to loud noise. If you are unsure which of those describes you, the differences are clinically meaningful and we have laid them out in misophonia, hyperacusis, or phonophobia.


Second, and this is the part the popular coverage skips: misophonia does not appear among the recognized symptoms of the menopause transition. The NICE guideline on identifying and managing menopause, updated in 2024, does not list it [3]. That absence is not proof of nothing — it partly reflects how little anyone has looked. But it does mean that anyone presenting sound sensitivity as an established menopause symptom is ahead of the evidence.


🔎 Key takeaway: "Menopausal misophonia" is a media phrase, not a diagnosis. The experience behind it is real; the framing that it is a new hormonal condition is not supported.

Why sound sensitivity can spike in your forties

Here is where I want to be careful, because this is the section where most of the content on this topic overstates what is known.


No study has directly examined misophonia across the menopause transition. What exists is a set of adjacent findings that make a spike biologically plausible. Plausible is worth knowing. It is not the same as demonstrated, and you should be suspicious of any page that presents this mechanism as settled.


Estrogen, GABA, and central auditory processing

Two lines of evidence are relevant.


The first concerns hearing itself. Estrogen appears to influence not just the ear but how the brain processes what the ear delivers. After menopause, many women report difficulty hearing while showing no measurable loss in peripheral hearing sensitivity — which points toward a central rather than peripheral change [4]. Measured directly, postmenopausal women have shown differences in spatial hearing and longer latencies on auditory brainstem and middle-latency responses compared with premenopausal women [4]. A 2023 systematic review of sex hormones and auditory function reached broadly consistent conclusions while noting the literature's real limitations [5].


The second concerns inhibition. Progesterone's metabolite allopregnanolone modulates the GABA-A receptor, the main inhibitory system in the central nervous system, and sensitivity to that modulation varies considerably between individuals — a mechanism studied most closely in premenstrual dysphoric disorder [6]. During perimenopause, these steroids fluctuate more erratically than they did before.


Put together: a system that filters and weights incoming sound, and a system that governs how much inhibitory braking is available, both shift during this window. A response that was previously containable becoming harder to contain is what you would predict.


What I am not telling you is that this has been shown for misophonia specifically. It has not. The honest statement is that the mechanism is coherent and partially evidenced at each step, with the final connecting study still missing.


Amplification vs onset — the distinction that matters

Ask yourself one question: were these sounds always a problem, or are they new?


If the triggers are the same ones you have had since your teens or twenties — the chewing, the pen clicking, the particular relative — and what has changed is the intensity and your ability to absorb it, you are almost certainly looking at amplification. This is by far the more common presentation, and it points toward two workable targets: treating the misophonia directly, and addressing whatever has eroded your margin.


Here is what amplification usually looks like from inside. You are fine at nine in the morning — your daughter eats cereal across the table and you barely register it. By six in the evening, after a night of waking at three and a day of holding yourself together at work, the same sound in the same kitchen produces something closer to rage, and you leave the room before you say something you will regret. The trigger did not change across those nine hours. What changed is that you spent the day's regulatory budget and had nothing left when the sound arrived. Women often describe this to me as "becoming a different person after about four o'clock," and the four-o'clock part is the clue.


If the sensitivity is genuinely new in midlife, with no prior history at all, that deserves a different conversation. New-onset sound intolerance in your forties is not automatically hormonal, and a few possibilities want ruling out — an audiological cause, a medication effect, or a mood or anxiety condition that has lowered your tolerance across the board. Untreated depression and anxiety both reduce sensory tolerance, and screeners like the PHQ-9 [7] and GAD-7 [8] are a reasonable starting point for that question, though neither can diagnose on its own.


There is also an overlap worth naming briefly: sound sensitivity, ADHD, and midlife are entangled in ways that get misattributed in both directions. We have covered that separately in misophonia and ADHD.


🎚️ Key takeaway: Same triggers, less tolerance is a different clinical problem from new triggers — and the second one needs a workup the first one does not.

Amplification versus onset decision framework for sound sensitivity that worsened during the menopause transition

What this does and does not change about treatment

Recognizing the hormonal context does not produce a different treatment for the sound response. It adds a second thing worth working on.


Cognitive behavioral approaches have the strongest evidence base for misophonia, though that base remains thin. A 2023 systematic review found only one randomized controlled trial alongside one open-label trial and 31 case studies [9]. In that randomized trial, 56% of participants who completed three months of group CBT showed meaningful improvement [10]. That is a real result and it is worth having in front of you honestly: helpful for many, not curative, and drawn from a small literature. We have compared the available approaches in more detail in misophonia treatment: CBT, sound therapy, and coping compared.


The addition, in this context, is the tolerance side. If sleep is broken, if hot flushes are fragmenting your nights, if your regulatory capacity is spent by four in the afternoon, then the sound work is being asked to succeed under conditions that make it harder. Those are managed by the clinician handling your menopause care, and it is reasonable to treat them as part of the same picture rather than a separate file.


What to be cautious of, including HRT claims

Hormone therapy is not a treatment for misophonia. There is no evidence that it treats the sound response, and starting or adjusting it for that reason is not supported. Hormone therapy has established indications in the menopause transition [3], and those are decisions for the clinician who manages your care. If your sleep and mood improve on it, your tolerance may improve too — but that is a downstream effect, and framing it as a treatment for misophonia oversells it.


Be wary of anything promising a cure. The evidence supports symptom reduction. It does not support elimination, and the supplement-adjacent content in this space frequently implies otherwise.


Be wary of standard exposure protocols delivered without misophonia-specific adaptation. The treatment literature here is small and specific, and a generic exposure approach borrowed from phobia treatment is not the same intervention.


🧪 Key takeaway: Recognizing the hormonal context does not change the treatment for the sound response. It adds a second, separately treatable problem: the tolerance that got worn down around it.

What helps misophonia in perimenopause: CBT evidence is supported, hormone therapy is not supported as a treatment

When to get evaluated

It is worth a conversation with a clinician if the sound response has begun shrinking your life — if you are eating separately, avoiding the office, declining invitations, or if it has become a live source of conflict at home. Also if it is genuinely new rather than amplified, and if you cannot tell whether you are dealing with a sound condition, a mood condition, or the aftermath of eighteen months of broken sleep. That last question is common and is a reasonable thing to bring in unresolved.


Questions worth asking a provider before you book:

  • Do you assess misophonia specifically, and what does that assessment involve?

  • How do you distinguish misophonia from hyperacusis, and would you refer for audiological testing?

  • How do you account for sleep disruption and mood when interpreting a change in sound tolerance?

  • What treatment do you offer for misophonia, and what does the evidence realistically support?


A psychological evaluation can sort out what is driving what when several possibilities are live at once, and our screening tools are a low-cost first step if you would rather start there. For treatment, our specialized therapy services cover the approaches above, and you can see who is on our team before you decide.


If there is one thing to take away: you did not become an unreasonable person in your forties. The sounds are the same. What changed is how much room you have around them — and that is a more tractable problem than the one you have probably been blaming yourself for.


Next step — getting support

Navigating a women's-health or hormonal change?


Hannah Pollok works at the intersection of physical and mental health — hormones, reproductive changes, and the mood and cognitive shifts that come with them.



Frequently Asked Questions

Does perimenopause cause misophonia, or make existing misophonia worse?

The evidence points toward amplification rather than onset. Misophonia is a distinct disorder of decreased sound tolerance with its own consensus definition, and it is not listed among the recognized symptoms of the menopause transition. What perimenopause plausibly changes is your capacity to tolerate triggers you already had — through disrupted sleep, shifting inhibitory signaling, and altered central auditory processing. The direct link has not been studied.


If I have always been sound-sensitive, why is it so much worse in my forties?

Most likely because tolerance is a moving target and yours has dropped, not because the underlying condition has changed. Sound tolerance depends on sleep, baseline arousal, and how much regulatory capacity you have left at the end of a day — all of which the menopause transition can affect. The trigger sounds are usually the same ones. What has changed is how much margin you have around them.


What do people mean by menopausal misophonia?

It is a popular phrase rather than a clinical one. It has appeared in women's-health media over the past year to describe sound sensitivity that becomes unmanageable during the menopause transition. There is no diagnosis by that name, no separate criteria, and no research literature using the term. Treat it as a useful shorthand for a real experience, not as a distinct condition.


Can hormone therapy treat sound sensitivity in perimenopause?

There is no evidence that hormone therapy treats misophonia, and it should not be started for that purpose. Hormone therapy has established indications in the menopause transition, and those decisions belong with the clinician who manages your care. If sleep or mood improve on it, sound tolerance may improve indirectly — but that is a downstream effect, not a treatment for the sound condition itself.



About the Author

Dr. Kiesa Kelly is a licensed clinical psychologist and the founder of ScienceWorks Behavioral Healthcare. Her clinical work includes the assessment of sensory and sound-tolerance conditions in adults, and the differential questions that surround them — where misophonia ends and anxiety, hyperacusis, or a neurodevelopmental profile begins.


Dr. Kelly brings more than two decades of experience in psychological assessment and evidence-based treatment, with particular attention to presentations in midlife women that are frequently attributed to stress before they are properly evaluated. She personally reviews ScienceWorks clinical content for accuracy and alignment with current diagnostic standards.


References

1. Swedo SE, Baguley DM, Denys D, et al. Consensus Definition of Misophonia: A Delphi Study. Front Neurosci. 2022;16:841816. https://doi.org/10.3389/fnins.2022.841816

2. Commentary: Consensus definition of misophonia. Front Neurosci. 2022;16:1077097. https://doi.org/10.3389/fnins.2022.1077097

3. National Institute for Health and Care Excellence. Menopause: identification and management. NICE guideline NG23. Updated November 2024. https://www.nice.org.uk/guidance/ng23

4. Hormones and Hearing: Central Auditory Processing in Women. J Am Acad Audiol. 2019;30(6). https://pubmed.ncbi.nlm.nih.gov/30461407/

5. Sex differences and the effect of female sex hormones on auditory function: a systematic review. Front Hum Neurosci. 2023;17:1077409. https://doi.org/10.3389/fnhum.2023.1077409

6. Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neurobiol Stress. 2020. https://www.sciencedirect.com/science/article/pii/S2352289520300035

7. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x

8. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097. https://doi.org/10.1001/archinte.166.10.1092

9. Mattson SA, D'Souza J, Wojcik KD, et al. A systematic review of treatments for misophonia. Personalized Medicine in Psychiatry. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10276561/

10. Jager I, Vulink N, Bergfeld I, van Loon A, Denys D. Cognitive behavioral therapy for misophonia: A randomized clinical trial. Depress Anxiety. 2021;38(7):708–718. https://doi.org/10.1002/da.23127


Disclaimer

This article is for informational purposes only and is not a substitute for individualized clinical advice, diagnosis, or treatment. Reading it does not create a clinician-patient relationship. Decisions about hormone therapy and other medical treatment belong with the clinician who manages your care. If you are concerned about your own functioning, please consult a qualified clinician who can evaluate your specific circumstances.

bottom of page